Dafydd Thomas

2.6k total citations · 1 hit paper
15 papers, 1.9k citations indexed

About

Dafydd Thomas is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Dafydd Thomas has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Dafydd Thomas's work include Platelet Disorders and Treatments (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Dafydd Thomas is often cited by papers focused on Platelet Disorders and Treatments (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Dafydd Thomas collaborates with scholars based in United States, France and United Kingdom. Dafydd Thomas's co-authors include Ian Tattersall, Ben Z. Stanger, Paul E. Oberstein, Stephen A. Sastra, Kenneth P. Olive, Maite G. Fernández‐Barrena, Emily T. Mirek, Andrew D. Rhim, Tyler Saunders and Carmine F. Palermo and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Cell.

In The Last Decade

Dafydd Thomas

14 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

2014 1.5k citations Andrew D. Rhim, Paul E. Oberstein et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dafydd Thomas United States	10	1.4k	693	507	438	287	15	1.9k
Andrew L. Coveler United States	22	1.1k 0.8×	481 0.7×	607 1.2×	268 0.6×	135 0.5×	105	1.7k
Nicholas Willumsen Denmark	26	811 0.6×	609 0.9×	366 0.7×	455 1.0×	178 0.6×	82	2.0k
Kristian Ikenberg Switzerland	28	833 0.6×	905 1.3×	245 0.5×	253 0.6×	323 1.1×	63	2.0k
Darren Sigal United States	19	876 0.6×	502 0.7×	345 0.7×	376 0.9×	113 0.4×	59	1.5k
Todd T. Moore United States	12	1.8k 1.3×	686 1.0×	1.4k 2.8×	373 0.9×	319 1.1×	17	2.8k
Dominic Fong Austria	21	916 0.7×	645 0.9×	241 0.5×	254 0.6×	213 0.7×	33	1.7k
Paul E. Oberstein United States	14	2.2k 1.6×	934 1.3×	625 1.2×	745 1.7×	388 1.4×	70	2.8k
Hao Yuan China	22	959 0.7×	1.4k 2.0×	418 0.8×	909 2.1×	152 0.5×	47	2.2k
Shinya Neri Japan	19	1.1k 0.8×	562 0.8×	341 0.7×	366 0.8×	131 0.5×	36	1.7k
Andrew S. Liss United States	23	1.1k 0.8×	735 1.1×	183 0.4×	541 1.2×	572 2.0×	56	1.8k

Countries citing papers authored by Dafydd Thomas

Since Specialization

Citations

This map shows the geographic impact of Dafydd Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dafydd Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dafydd Thomas more than expected).

Fields of papers citing papers by Dafydd Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dafydd Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dafydd Thomas. The network helps show where Dafydd Thomas may publish in the future.

Co-authorship network of co-authors of Dafydd Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Dafydd Thomas. A scholar is included among the top collaborators of Dafydd Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dafydd Thomas. Dafydd Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Harms, Paul W., Timothy L. Frankel, Myrto Moutafi, et al.. (2023). Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists. Modern Pathology. 36(7). 100197–100197. 69 indexed citations

Coffey, David G., Yuexin Xu, Andrea Towlerton, et al.. (2022). Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancer. Frontiers in Immunology. 13. 961105–961105.

Poznak, Catherine Van, Evan L. Reynolds, Cherry L. Estilo, et al.. (2020). Osteonecrosis of the jaw risk factors in bisphosphonate‐treated patients with metastatic cancer. Oral Diseases. 28(1). 193–201. 7 indexed citations

Mazhar, Sahar, Daniel Léonard, Alejandro Jiménez, et al.. (2020). Challenges and Reinterpretation of Antibody-Based Research on Phosphorylation of Tyr307 on PP2Ac. Cell Reports. 30(9). 3164–3170.e3. 16 indexed citations

Smith, Harry, Tim Cooksley, Dafydd Thomas, et al.. (2020). Correction: Checklists for Complications During Systemic Cancer Treatment Shared by Patients, Friends, and Health Care Professionals: Prospective Interventional Cohort Study. JMIR mhealth and uhealth. 8(10). e24816–e24816. 1 indexed citations

Smith, Harry, Tim Cooksley, Dafydd Thomas, et al.. (2020). Checklists for Complications During Systemic Cancer Treatment Shared by Patients, Friends, and Health Care Professionals: Prospective Interventional Cohort Study. JMIR mhealth and uhealth. 8(9). e19225–e19225. 6 indexed citations

Dangelmaier, Carol, Dafydd Thomas, Nick Carpino, et al.. (2016). TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)346, a Regulatory Site of Syk. Journal of Biological Chemistry. 291(43). 22427–22441. 26 indexed citations

Rhim, Andrew D., Paul E. Oberstein, Dafydd Thomas, et al.. (2014). Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma. Cancer Cell. 25(6). 735–747. 1513 indexed citations breakdown →

Hauff, Samantha J., Alice L. Tang, Dafydd Thomas, et al.. (2012). Head and neck squamous cell carcinoma in pregnant women. Head & Neck. 35(3). 335–342. 18 indexed citations

10.

Light, Emily, Dafydd Thomas, Francis P. Worden, et al.. (2011). Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancer. The Laryngoscope. 122(1). 121–127. 115 indexed citations

11.

Thomas, Dafydd, Todd M. Getz, Tiffanny Newman, et al.. (2010). A novel histidine tyrosine phosphatase, TULA-2, associates with Syk and negatively regulates GPVI signaling in platelets. Blood. 116(14). 2570–2578. 54 indexed citations

12.

Dangelmaier, Carol, et al.. (2010). Curcumin inhibits GPVI-mediated platelet activation by interfering with the kinase activity of Syk and the subsequent activation of PLCγ2. Platelets. 21(3). 211–220. 33 indexed citations

13.

Jin, Jianguo, Yingying Mao, Dafydd Thomas, et al.. (2008). RhoA downstream of Gq and G12/13 pathways regulates protease-activated receptor-mediated dense granule release in platelets. Biochemical Pharmacology. 77(5). 835–844. 39 indexed citations

14.

Thomas, Dafydd, Carol Dangelmaier, Jianguo Jin, et al.. (2008). A Novel Histidine Tyrosine Phosphatase, TULA-2, Associates with Syk and Negatively Regulates GPVI Signaling in Platelets.. Blood. 112(11). 1843–1843. 2 indexed citations

15.

Springer, Stephanie, et al.. (1977). Experimental pancreatic carcinogenesis. I. Morphogenesis of pancreatic adenocarcinoma in the Syrian golden hamster induced by N-nitroso-bis(2-hydroxypropyl)amine.. PubMed Central. 88(1). 5–28. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact